When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADCT - FDA halts enrollment in mid-stage study of ADC Therapeutics' camidanlumab tesirine
ADC Therapeutics SA
The FDA has placed a partial clinical hold on a pivotal Phase 2 clinical trial evaluating ADC Therapeutics' (NYSE:ADCT) antibody-drug conjugate camidanlumab tesirine in patients with relapsed/refractory Hodgkin lymphoma.
More news on: ADC Therapeutics SA, Genmab A/S, Healthcare stocks news,